Search Results - "E. Svensson, Jonas"

Is serotonin transporter brain binding associated with the cortisol awakening response? An independent non-replication by Conradi, Juliane, E. Svensson, Jonas, V. Larsen, Søren, Frokjaer, Vibe G

“…Background Serotonergic brain signaling is considered critical for an appropriate and dynamic adaptation to stress, seemingly through modulating limbic system…”
Get full text

Validity and reliability of extrastriatal [11C]raclopride binding quantification in the living human brain by Svensson, Jonas E., Schain, Martin, Plavén-Sigray, Pontus, Cervenka, Simon, Tiger, Mikael, Nord, Magdalena, Halldin, Christer, Farde, Lars, Lundberg, Johan

“…[11C]raclopride is a well established PET tracer for the quantification of dopamine 2/3 receptors (D2/3R) in the striatum. Outside of the striatum the receptor…”
Get full text

Low convergent validity of [11C]raclopride binding in extrastriatal brain regions: A PET study of within-subject correlations with [11C]FLB 457 by Freiburghaus, Tove, Svensson, Jonas E., Matheson, Granville J., Plavén-Sigray, Pontus, Lundberg, Johan, Farde, Lars, Cervenka, Simon

“…Dopamine D2 receptors (D2-R) in extrastriatal brain regions are of high interest for research in a wide range of psychiatric and neurologic disorders…”
Get full text

Serotonin transporter availability increases in patients recovering from a depressive episode by Svensson, Jonas E., Svanborg, Cecilia, Plavén-Sigray, Pontus, Kaldo, Viktor, Halldin, Christer, Schain, Martin, Lundberg, Johan

“…Molecular imaging studies have shown low cerebral concentration of serotonin transporter in patients suffering from depression, compared to healthy control…”
Get full text

In response to the letter “[11C]raclopride and extrastriatal binding to D2/3 receptors” by Svensson, Jonas E., Schain, Martin, Plavén-Sigray, Pontus, Cervenka, Simon, Tiger, Mikael, Nord, Magdalena, Halldin, Christer, Farde, Lars, Lundberg, Johan

“…[...]Dr. Backes proposes that our findings of low or non-existing dopamine D2/3-receptor (D2/3R) occupancy of quetiapine in extrastriatal regions could be…”
Get full text

Evaluating the effect of rapamycin treatment in Alzheimer's disease and aging using in vivo imaging: the ERAP phase IIa clinical study protocol by Svensson, Jonas E, Bolin, Martin, Thor, Daniel, Williams, Pete A, Brautaset, Rune, Carlsson, Marcus, Sörensson, Peder, Marlevi, David, Spin-Neto, Rubens, Probst, Monika, Hagman, Göran, Morén, Anton Forsberg, Kivipelto, Miia, Plavén-Sigray, Pontus

“…Rapamycin is an inhibitor of the mechanistic target of rapamycin (mTOR) protein kinase, and preclinical data demonstrate that it is a promising candidate for a…”
Get full text

In vivo correlation of serotonin transporter and 1B receptor availability in the human brain: a PET study by Svensson, Jonas E, Tiger, Mikael, Plavén-Sigray, Pontus, Halldin, Christer, Schain, Martin, Lundberg, Johan

“…Abstract Synaptic serotonin levels in the brain are regulated by active transport into the bouton by the serotonin transporter, and by autoreceptors, such as…”
Get full text

Prediction of brain age using structural magnetic resonance imaging: A comparison of accuracy and test–retest reliability of publicly available software packages by Dörfel, Ruben P., Arenas‐Gomez, Joan M., Fisher, Patrick M., Ganz, Melanie, Knudsen, Gitte M., Svensson, Jonas E., Plavén‐Sigray, Pontus

“…Abstract Brain age prediction algorithms using structural magnetic resonance imaging (MRI) aim to assess the biological age of the human brain. The difference…”
Get full text

Early stopping in clinical PET studies: How to reduce expense and exposure by Svensson, Jonas E, Schain, Martin, Knudsen, Gitte M, Ogden, R Todd, Plavén-Sigray, Pontus

“…Clinical positron emission tomography (PET) research is costly and entails exposing participants to radioactivity. Researchers should therefore aim to include…”
Get full text

Multimodal brain age prediction using machine learning: combining structural MRI and 5-HT2AR PET-derived features by Dörfel, Ruben P., Arenas-Gomez, Joan M., Svarer, Claus, Ganz, Melanie, Knudsen, Gitte M., Svensson, Jonas E., Plavén-Sigray, Pontus

“…To better assess the pathology of neurodegenerative disorders and the efficacy of neuroprotective interventions, it is necessary to develop biomarkers that can…”
Get full text